Chemicals · Founded 1939 · www.tatachemicals.com · BSE 500770 · NSE TATA CHEM. · ISIN INE092A01019
No Notes Added Yet
Business
Tata Chemicals Ltd. is a leading global producer of basic and specialty chemistry products. Its core business model revolves around two main pillars:
Basic Chemistry Products: This segment includes industrial chemicals such as soda ash, sodium bicarbonate, cement, and industrial salt. These products are essential raw materials for various industries including glass, detergents, food, animal feed, and pharmaceuticals.
Specialty Products: This segment focuses on higher-value, differentiated products in areas like nutrition sciences (e.g., prebiotics, silica for food & feed), crop protection (agri-sciences), and material sciences (e.g., highly dispersible silica for tires).
The company makes money by manufacturing and selling these chemical products to a diverse customer base across industrial, agricultural, and consumer sectors globally.
Revenue Mix
Tata Chemicals primarily operates through two distinct business segments:
Basic Chemistry Products: This segment historically contributes a larger portion of the revenue, encompassing its commodity chemicals portfolio with significant manufacturing presence in India, UK, USA, and Kenya.
Specialty Products: While smaller in revenue contribution currently, this segment is the focus for future growth and higher margins, including nutritional products, crop protection chemicals, and advanced materials like precipitated silica.
Specific revenue contribution percentages for each segment can vary year-on-year based on market conditions and strategic shifts, but the company is actively increasing its focus and investments in the Specialty Products segment.
Industry
Tata Chemicals operates within the highly diversified global chemicals industry, which includes both cyclical commodity chemicals and more stable, innovation-driven specialty chemicals.
Industry Structure: The basic chemicals market is often characterized by large-scale production, capital intensity, and commodity price volatility, with global competition. The specialty chemicals market is more fragmented, driven by R&D, application expertise, and customer-specific solutions.
Positioning: Tata Chemicals is one of India's largest chemical companies and a globally significant player in soda ash, with a strong market position across its geographies. It holds a leadership position in certain products like soda ash and sodium bicarbonate. In specialty chemicals, it is growing its presence and aims to be a significant player in niche, high-growth areas, leveraging its R&D capabilities and backward integration.
MOAT
Scale & Cost Leadership: As one of the world's largest soda ash producers, Tata Chemicals benefits from economies of scale, operational efficiencies, and in some cases, backward integration into raw materials (e.g., salt), which helps in maintaining a competitive cost structure.
Global Footprint: Diversified manufacturing bases and sales networks across India, North America, Europe, and Africa provide geographical diversification, reducing dependence on a single market and offering resilience.
R&D and Innovation: Growing focus and investment in research and development, particularly in specialty chemicals, enables the creation of proprietary products and solutions, fostering differentiation.
Brand Equity (Tata Group): Being part of the Tata Group confers a strong reputation for corporate governance, reliability, and financial stability, which can be an advantage in B2B relationships and talent attraction.
Growth Drivers
Shift to Specialty Chemicals: Strategic focus on expanding the higher-margin Specialty Products portfolio (e.g., nutrition, crop protection, silica) will drive revenue and profitability growth.
Industrial Demand Growth: Continued industrialization and economic growth in India and other emerging markets will fuel demand for basic chemistry products (glass, detergents, paper).
Innovation & New Product Development: Investment in R&D to develop new applications and advanced materials will open up new market opportunities.
Sustainability Trends: Growing global demand for sustainable solutions, cleaner technologies, and green chemistry aligns with Tata Chemicals' product development in areas like advanced materials for EV batteries and nutrition.
Geographical Expansion: Tapping into underserved markets or expanding market share in existing regions for both segments.
Risks
Commodity Price Volatility: Fluctuations in prices of basic chemicals (soda ash, caustic soda) and key raw materials can significantly impact profitability.
Regulatory & Environmental Risks: Stringent environmental regulations, permit renewals, and compliance costs can pose operational and financial challenges.
Geopolitical & Macroeconomic Risks: Global economic slowdowns, trade wars, currency fluctuations, and political instability in operating geographies can affect demand, supply chains, and profitability.
Intense Competition: Competition from both domestic and international players in basic and specialty chemical markets can put pressure on pricing and market share.
Technological Disruption: Rapid technological advancements or shifts in customer preferences could necessitate significant R&D investments or render existing products less competitive.
Management & Ownership
Promoters: Tata Chemicals is part of the venerable Tata Group, one of India's largest and most respected conglomerates. Tata Sons, the promoter group, holds a significant stake in the company.
Management Quality: The company benefits from the Tata Group's strong corporate governance framework, professional management, and a long-term strategic vision. Leadership typically has extensive industry experience.
Ownership Structure: The promoter group maintains a controlling stake, ensuring stable ownership and strategic direction aligned with the broader Tata Group philosophy. The remaining shares are held by institutional investors and the public.
Outlook
Tata Chemicals is navigating a strategic transition, aiming to increase its proportion of higher-margin, innovative specialty products while maintaining its strong foundational business in basic chemicals. The company is well-positioned to benefit from industrial growth in emerging economies and the global shift towards sustainable and healthier living (nutrition, advanced materials). However, its performance remains susceptible to the inherent cyclicality of commodity chemicals, raw material price volatility, and global macroeconomic conditions. The success of its specialty chemicals expansion, coupled with efficient management of its large basic chemicals portfolio, will be crucial for its long-term growth and profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3730 | 3475 | 3789 | 3999 | 3590 | 3509 | 3719 | 3877 | 3550 | 3438 |
| Other Income | 38 | 114 | 47 | 108 | 28 | 42 | 96 | 138 | 38 | 44 |
| Total Income | 3768 | 3589 | 3836 | 4107 | 3618 | 3551 | 3815 | 4015 | 3588 | 3482 |
| Total Expenditure | 3188 | 3032 | 3215 | 3381 | 3156 | 3182 | 3070 | 3340 | 3205 | 3164 |
| Operating Profit | 580 | 557 | 621 | 726 | 462 | 369 | 745 | 675 | 383 | 318 |
| Interest | 132 | 130 | 133 | 145 | 148 | 137 | 147 | 144 | 146 | 153 |
| Depreciation | 246 | 271 | 273 | 277 | 280 | 293 | 280 | 285 | 293 | 343 |
| Exceptional Income / Expenses | 0 | -963 | 0 | 0 | -70 | -55 | 0 | -65 | -54 | -1837 |
| Profit Before Tax | 202 | -807 | 215 | 304 | -36 | -116 | 318 | 181 | -110 | -2015 |
| Provision for Tax | 68 | 22 | 94 | 81 | 17 | -25 | 44 | 82 | -4 | 134 |
| Profit After Tax | 134 | -829 | 121 | 223 | -53 | -91 | 274 | 99 | -106 | -2149 |
| Adjustments | 24 | -21 | 29 | -29 | 0 | 35 | -22 | -22 | 13 | 17 |
| Profit After Adjustments | 158 | -850 | 150 | 194 | -53 | -56 | 252 | 77 | -93 | -2132 |
| Adjusted Earnings Per Share | 6.2 | -33.3 | 5.9 | 7.6 | -2.1 | -2.2 | 9.9 | 3 | -3.6 | -83.6 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 14873 | 10346 | 10270 | 10337 | 10357 | 10200 | 12622 | 16789 | 15421 | 14887 | 14584 | 14584 |
| Other Income | 125 | 296 | 182 | 427 | 311 | 235 | 260 | 218 | 286 | 225 | 316 | 316 |
| Total Income | 14998 | 10642 | 10451 | 10763 | 10668 | 10435 | 12882 | 17007 | 15707 | 15112 | 14900 | 14900 |
| Total Expenditure | 12781 | 8252 | 8083 | 8556 | 8408 | 8699 | 10321 | 12967 | 12574 | 12934 | 12779 | 12779 |
| Operating Profit | 2217 | 2390 | 2368 | 2207 | 2260 | 1735 | 2561 | 4040 | 3133 | 2178 | 2121 | 2121 |
| Interest | 525 | 427 | 344 | 371 | 342 | 368 | 303 | 406 | 530 | 563 | 590 | 590 |
| Depreciation | 526 | 512 | 518 | 569 | 666 | 759 | 806 | 892 | 980 | 1123 | 1201 | 1201 |
| Exceptional Income / Expenses | 0 | 0 | 64 | 70 | 0 | 0 | -11 | 0 | -861 | -125 | -1956 | -1956 |
| Profit Before Tax | 1180 | 1467 | 1620 | 1437 | 1248 | 634 | 1667 | 2740 | 830 | 521 | -1459 | -1626 |
| Provision for Tax | 248 | 346 | 60 | 274 | 220 | 198 | 267 | 288 | 381 | 167 | 256 | 256 |
| Profit After Tax | 932 | 1121 | 1560 | 1163 | 1028 | 436 | 1400 | 2452 | 449 | 354 | -1715 | -1882 |
| Adjustments | -161 | -128 | 873 | -7 | 5978 | -180 | -142 | -135 | -181 | -119 | -181 | -14 |
| Profit After Adjustments | 771 | 993 | 2433 | 1156 | 7006 | 256 | 1258 | 2317 | 268 | 235 | -1896 | -1896 |
| Adjusted Earnings Per Share | 30.2 | 39 | 95.5 | 45.4 | 275 | 10.1 | 49.3 | 90.9 | 10.5 | 9.2 | -74.4 | -74.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -2% | -5% | 7% | -0% |
| Operating Profit CAGR | -3% | -19% | 4% | -0% |
| PAT CAGR | -584% | NAN% | NAN% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -23% | -10% | -1% | 5% |
| ROE Average | -8% | -1% | 3% | 8% |
| ROCE Average | -3% | 2% | 5% | 8% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 6854 | 7908 | 11102 | 12341 | 12898 | 14290 | 18253 | 19721 | 22241 | 21594 | 21206 |
| Minority's Interest | 2598 | 2624 | 2717 | 2915 | 764 | 853 | 904 | 921 | 873 | 907 | 969 |
| Borrowings | 6780 | 4361 | 5394 | 4769 | 3473 | 5199 | 3725 | 5540 | 2898 | 4166 | 4663 |
| Other Non-Current Liabilities | 3089 | 3088 | 2942 | 2895 | 3514 | 3532 | 3865 | 3854 | 4644 | 4944 | 5417 |
| Total Current Liabilities | 5025 | 5094 | 3153 | 3949 | 7025 | 4463 | 7096 | 4904 | 6055 | 6139 | 6743 |
| Total Liabilities | 24346 | 23587 | 25858 | 26869 | 27673 | 28337 | 33843 | 34940 | 36711 | 37750 | 38998 |
| Fixed Assets | 13431 | 12638 | 12759 | 13524 | 15334 | 15206 | 15990 | 17040 | 17809 | 19550 | 20572 |
| Other Non-Current Assets | 3336 | 3574 | 4060 | 5247 | 4540 | 6485 | 9108 | 9736 | 12535 | 11480 | 11220 |
| Total Current Assets | 7576 | 5836 | 7941 | 8098 | 7795 | 6642 | 8741 | 8160 | 6358 | 6720 | 7203 |
| Total Assets | 24346 | 23587 | 25858 | 26869 | 27673 | 28337 | 33843 | 34940 | 36711 | 37750 | 38998 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1179 | 1247 | 1451 | 3946 | 1888 | 1254 | 689 | 762 | 508 | 425 | 548 |
| Cash Flow from Operating Activities | 2332 | 3531 | 1870 | 1581 | 1780 | 2037 | 1645 | 2971 | 3016 | 1761 | 1269 |
| Cash Flow from Investing Activities | -489 | -982 | 2707 | -1958 | -2368 | -1130 | -836 | -1186 | -610 | -1681 | -809 |
| Cash Flow from Financing Activities | -1802 | -2341 | -2089 | -1712 | -129 | -1456 | -755 | -2076 | -2494 | 29 | -670 |
| Net Cash Inflow / Outflow | 42 | 207 | 2488 | -2089 | -717 | -549 | 54 | -291 | -88 | 109 | -210 |
| Closing Cash & Cash Equivalent | 1247 | 1451 | 3946 | 1888 | 1254 | 689 | 762 | 508 | 425 | 548 | 381 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 30.25 | 38.98 | 95.5 | 45.37 | 275.02 | 10.06 | 49.33 | 90.86 | 10.51 | 9.22 | -74.35 |
| CEPS(Rs) | 57.23 | 64.09 | 81.57 | 67.96 | 66.53 | 46.93 | 86.51 | 131.14 | 56.04 | 57.92 | -20.16 |
| DPS(Rs) | 10 | 11 | 22 | 12.5 | 11 | 10 | 12.5 | 17.5 | 15 | 11 | 11 |
| Book NAV/Share(Rs) | 269.05 | 310.42 | 435.77 | 484.42 | 506.26 | 560.92 | 715.8 | 773.37 | 872.2 | 846.82 | 831.61 |
| Core EBITDA Margin(%) | 13.74 | 19.61 | 21.14 | 16.91 | 17.56 | 13.6 | 17.22 | 21.61 | 17.31 | 12.26 | 11.5 |
| EBIT Margin(%) | 11.21 | 17.73 | 18.98 | 17.18 | 14.33 | 9.08 | 14.75 | 17.79 | 8.27 | 6.81 | -5.54 |
| Pre Tax Margin(%) | 7.76 | 13.73 | 15.66 | 13.65 | 11.25 | 5.75 | 12.48 | 15.5 | 5.05 | 3.27 | -9.3 |
| PAT Margin (%) | 6.12 | 10.49 | 15.08 | 11.05 | 9.27 | 3.95 | 10.48 | 13.87 | 2.73 | 2.22 | -10.93 |
| Cash Profit Margin (%) | 9.58 | 15.29 | 20.09 | 16.45 | 15.27 | 10.84 | 16.51 | 18.91 | 8.69 | 9.27 | -3.28 |
| ROA(%) | 3.87 | 4.68 | 6.31 | 4.41 | 3.77 | 1.56 | 4.5 | 7.13 | 1.25 | 0.95 | -4.47 |
| ROE(%) | 15.11 | 15.18 | 16.41 | 9.92 | 8.15 | 3.21 | 8.6 | 12.91 | 2.14 | 1.62 | -8.01 |
| ROCE(%) | 11.45 | 12.25 | 12.2 | 10.13 | 8.18 | 4.84 | 8.57 | 12.37 | 5.12 | 3.93 | -3.09 |
| Receivable days | 83.84 | 96.67 | 59.98 | 47.86 | 49.87 | 49.25 | 45.49 | 47.06 | 50.22 | 43.55 | 46.38 |
| Inventory Days | 54.66 | 56.69 | 50.25 | 55.27 | 59.11 | 58.83 | 54.38 | 49.81 | 56.09 | 58.24 | 65.59 |
| Payable days | 106.87 | 257.94 | 291.36 | 269.28 | 288 | 252.31 | 285.68 | 268.44 | 301.15 | 273.43 | 250.14 |
| PER(x) | 12.34 | 15.36 | 7.09 | 12.95 | 0.81 | 74.65 | 19.75 | 10.7 | 102.82 | 93.87 | 0 |
| Price/Book(x) | 1.39 | 1.93 | 1.55 | 1.21 | 0.44 | 1.34 | 1.36 | 1.26 | 1.24 | 1.02 | 0.7 |
| Dividend Yield(%) | 2.68 | 1.84 | 3.25 | 2.13 | 4.93 | 1.33 | 1.28 | 1.8 | 1.39 | 1.27 | 1.89 |
| EV/Net Sales(x) | 1.17 | 2 | 1.84 | 1.85 | 1.07 | 2.39 | 2.4 | 1.8 | 2.07 | 1.86 | 1.48 |
| EV/Core EBITDA(x) | 7.82 | 8.65 | 7.97 | 8.67 | 4.92 | 14.05 | 11.85 | 7.48 | 10.21 | 12.74 | 10.16 |
| Net Sales Growth(%) | -13.55 | -30.44 | -0.74 | 0.65 | -19.16 | -1.52 | 23.75 | 33.01 | -8.15 | -3.46 | -2.04 |
| EBIT Growth(%) | 5.33 | 11 | 3.73 | -7.94 | -20.58 | -36.99 | 101.81 | 59.7 | -56.77 | -20.29 | -180.17 |
| PAT Growth(%) | 15.43 | 20.25 | 39.21 | -25.46 | -20.13 | -57.58 | 240.96 | 75.14 | -81.69 | -21.16 | -584.46 |
| EPS Growth(%) | 29.19 | 28.88 | 145 | -52.49 | 506.13 | -96.34 | 390.23 | 84.18 | -88.43 | -12.31 | -906.81 |
| Debt/Equity(x) | 1.33 | 0.89 | 0.55 | 0.5 | 0.58 | 0.47 | 0.37 | 0.31 | 0.23 | 0.29 | 0.34 |
| Current Ratio(x) | 1.51 | 1.15 | 2.52 | 2.05 | 1.11 | 1.49 | 1.23 | 1.66 | 1.05 | 1.09 | 1.07 |
| Quick Ratio(x) | 1.12 | 0.87 | 2.05 | 1.61 | 0.84 | 1.11 | 0.91 | 1.15 | 0.63 | 0.68 | 0.61 |
| Interest Cover(x) | 3.25 | 4.44 | 5.71 | 4.88 | 4.65 | 2.72 | 6.5 | 7.75 | 2.57 | 1.93 | -1.47 |
| Total Debt/Mcap(x) | 0.96 | 0.46 | 0.35 | 0.41 | 1.32 | 0.35 | 0.27 | 0.25 | 0.18 | 0.29 | 0.48 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 |
| FII | 14.06 | 13.83 | 13.76 | 13.56 | 13.6 | 13.29 | 12.84 | 13.73 | 12.26 | 11.9 |
| DII | 20.48 | 20 | 19.94 | 20.37 | 21.71 | 21.99 | 22.64 | 22.21 | 22.42 | 22.87 |
| Public | 27.48 | 28.19 | 28.32 | 28.09 | 26.71 | 26.74 | 26.53 | 26.08 | 27.34 | 27.25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 9.67 | 9.67 | 9.67 | 9.67 | 9.67 | 9.67 | 9.68 | 9.68 | 9.68 | 9.67 |
| FII | 3.58 | 3.52 | 3.51 | 3.45 | 3.47 | 3.39 | 3.27 | 3.5 | 3.12 | 3.03 |
| DII | 5.22 | 5.09 | 5.08 | 5.19 | 5.53 | 5.6 | 5.77 | 5.66 | 5.71 | 5.83 |
| Public | 7 | 7.18 | 7.21 | 7.16 | 6.8 | 6.81 | 6.76 | 6.64 | 6.96 | 6.94 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -2% | -5% | +7% | 0% |
| Operating Profit CAGR | -3% | -19% | +4% | 0% |
| PAT CAGR | -584% | 0% | 0% | 0% |
| Share Price CAGR | -23% | -10% | -1% | +5% |
| ROE Average | -8% | -1% | +3% | +8% |
| ROCE Average | -3% | +2% | +5% | +8% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 |
| FII | 14.06 | 13.83 | 13.76 | 13.56 | 13.6 | 13.29 | 12.84 | 13.73 | 12.26 | 11.9 |
| DII | 20.48 | 20 | 19.94 | 20.37 | 21.71 | 21.99 | 22.64 | 22.21 | 22.42 | 22.87 |
| Public | 62.02 | 62.02 | 62.02 | 62.02 | 62.02 | 62.02 | 62.02 | 62.02 | 62.02 | 62.02 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 9.67 | 9.67 | 9.67 | 9.67 | 9.67 | 9.67 | 9.68 | 9.68 | 9.68 | 9.67 |
| FII | 3.58 | 3.52 | 3.51 | 3.45 | 3.47 | 3.39 | 3.27 | 3.5 | 3.12 | 3.03 |
| DII | 5.22 | 5.09 | 5.08 | 5.19 | 5.53 | 5.6 | 5.77 | 5.66 | 5.71 | 5.83 |
| Public | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 | 25.48 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.